Company / Operating Cash Flow per Share
CASTLE BIOSCIENCES INC Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.17
FY2025
5-year range
-$1.57 / $2.28
FY2021-FY2025
Trend
-4.8%
vs FY2024
Sector context
#87 of 162
Health Care
What the data says
At $2.17, CASTLE BIOSCIENCES INC's operating cash flow per share ranks #87 of 162 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-6.45 in FY2018 to $3.66 in FY2019.
Based on SEC 10-K filings.
2.17 in FY2025 with a 5-year CAGR of +30.4%.
Improved from $-0.21 to $2.17 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +30.4%
- 10-Year CAGR
- -
Sector benchmark
#87 of 162 in Health CareTop 54% of 162This company $2.17 Sector average $6.63
▼
-67.3% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 4.8% year-over-year.
- Ranks #87 out of 162 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.17 | -4.8% |
| FY2024 | $2.28 | +1174.9% |
| FY2023 | -$0.21 | +86.5% |
| FY2022 | -$1.57 | -109.7% |
| FY2021 | -$0.75 | -229.9% |
| FY2020 | $0.58 | -84.3% |
| FY2019 | $3.66 | +156.8% |
| FY2018 | -$6.45 | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026